Cures & Capital
Hello and welcome to Cures & Capital - the podcast on value creation in biotech and pharma.
Together, we are going to dive deep into the world of biotech and pharma to tackle the holy grail - how do we improve return on investment from drug innovation and deliver transformative therapies to patients, efficiently and sustainably.
Hosted by Martin Slezak & Simon Birksø
Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.
Episodes
13 episodes
Dr. Andrée Bates on AI that works: from pilot chaos to real impact
In this episode, we talk to Dr. Andrée Bates, founder and CEO of Eularis, a company helping clients accelerate pharma business results through Artificial Intelligence.We explore how the biopharma industry can move beyond scatt...
•
Season 1
•
Episode 13
•
1:18:59
Leon 'Jun' Tang: Inside the Rise of China's Biotech Industry
How did China become a serious force in global biotech in just over a decade?This is the insider story of China's biotech boom!Dr. Leon 'Jun' Tang, founding partner of InScienceWeTrust BioAdvisory, joins Cures & Capital to unp...
•
Season 1
•
Episode 12
•
1:18:29
Jason O'Neill on cracking the code to successful drug launches - Part 2
In this episode, we talk to Jason O’Neill, former CEO of Dendreon and Iridium Therapeutics, and author of The Secrets of Successful Drug Launches.This conversation is a practical guide to new drug launches, packed with Jason's hard-won ...
•
Season 1
•
Episode 10
•
52:39
Jason O'Neill on cracking the code to successful drug launches - Part 1
In this episode, we talk to Jason O’Neill, former CEO of Dendreon and Iridium Therapeutics, and author of The Secrets of Successful Drug Launches.This conversation is a practical guide to new drug launches, packed with Jason's hard-won ...
•
Season 1
•
Episode 10
•
42:08
Episode 9 - Reflections and Takeaways
Over the past few months, we’ve had the chance to speak with some of the sharpest minds in the industry—thinkers and practitioners who have shaped how we understand drug innovation, R&D productivity, portfolio strategy, and other critical t...
•
Season 1
•
Episode 9
•
33:30
Aaron Schacht on the pharmaceutical industry's grand challenge and managing R&D at scale
In this episode, we talk to Aaron Schact, the CEO and Board Director at BiomEdit and former R&D leader at Eli Lilly and Elanco. We discuss how to improve biopharma's R&D productivity and the industry's "grand challenge", wh...
•
53:52
Matthias Krings on crafting winning biopharma strategies and smart decisions
In this episode, our guest is Dr. Matthias Krings - a senior partner at Catenion, a biopharma strategy consulting firm.Matthias is a seasoned veteran in biopharma strategy.In this conversation, he shares his playbook for achieving...
•
Season 1
•
Episode 7
•
49:42
Stephan Christgau on applying the VC mindset in biotech & pharma
How do venture capitalists think? And how do they define and create value in the life science industry?In this episode, we talk to Stephan Christgau, founding partner of Eir Ventures, about the VC mindset, investment decision-making and...
•
1:03:16
Murray Aitken's guide to biotech & pharma leaders: Navigating great uncertainty and complexity
In this episode, we sit down with Murray Aitken, Executive Director of the IQVIA Institute for Human Data Science, to discuss the trends shaping the life sciences industry in 2025 and beyond.How do we navigate the life sciences industry ...
•
Season 1
•
Episode 5
•
1:00:30
Mike Rea on why pharma struggles with innovation - and how to fix it
In this episode, Mike Rea - CEO, IDEA Pharma - takes us on a journey through innovation and value creation in pharma. It is not all roses!He shares his candid views on what the pharmaceutical industry needs to do better to be less confus...
•
Season 1
•
Episode 4
•
1:08:13
Kelvin Stott on what it takes to fix pharma's broken business model
In this episode, Kelvin Stott talks about why might be pharma's business model broken and how can it be fixed, the declining ROI on drug R&D, better R&D portfolio decision making, raising the bar in pharma/biotech innovation and more.&n...
•
Season 1
•
Episode 3
•
1:00:42
Jack Scannell on drug R&D decision-making: The value of getting it right
In this episode, Dr. Jack Scannell delves into topics such as R&D productivity, decision-making, model validity, and more.If you're looking to deepen your understanding of these areas, there's no better guide than Jack.Jack ...
•
Season 1
•
Episode 2
•
1:18:24